As of June 1, 2025, Raffles Medical Group Ltd (BSL.SI) reports a ROE (Return on Equity) of 5.93%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Raffles Medical Group Ltd's ROE (Return on Equity)
Over recent years, Raffles Medical Group Ltd's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 5.93% |
| 2023-12-31 | 8.77% |
| 2022-12-31 | 14.15% |
| 2021-12-31 | 8.76% |
| 2020-12-31 | 7.33% |
This slight downward trend highlights how Raffles Medical Group Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Raffles Medical Group Ltd's ROE (Return on Equity) to Peers
To better understand Raffles Medical Group Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Raffles Medical Group Ltd (BSL.SI) | 5.93% |
| Regis Healthcare Ltd (REG.AX) | 93.58% |
| Narayana Hrudayalaya Ltd (NH.NS) | 27.37% |
| Amvis Holdings Inc (7071.T) | 22.40% |
| Rici Healthcare Holdings Ltd (1526.HK) | 22.09% |
| Singapore O&G Ltd (1D8.SI) | 19.57% |
Compared to its competitors, Raffles Medical Group Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.